François Santinon et al.
Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti–Tumor Necrosis Factor Treatments in Rheumatoid Arthritis
Arthritis & Rheumatology 2019
doi: 10.1002/art.41134